Updates from The Motley Fool

Latest updates on AstraZeneca plc (ADR) from Fool.com.

Stock Performance

AZN vs. S&P 500 | 2 Year Performance
AZN 1-Day Stock Chart
AZN 5-Day Stock Chart
AZN 1-Month Stock Chart
AZN 3-Month Stock Chart
AZN 6-Month Stock Chart
AZN 1-Year Stock Chart
AZN 2-Year Stock Chart
AZN 5-Year Stock Chart
View Interactive AZN Charts
Sponsored by

Key Data Points

Primary metrics and data points about AstraZeneca plc (ADR).
Current Price: $29.88
Prev Close: $29.95
Open: $29.58
Bid: $29.62
Ask: $30.10
Day's Range: $29.58 - $29.90
52wk Range: $27.68 - $34.88
Volume: 4,898,972
Avg Vol 3,797,338
Market Cap: $75.54B
P/E (ttm): 13.43
EPS (ttm): $2.23
Div & Yield: $0.90 (4.6%)

Company Rating

What our community thinks about AstraZeneca plc (ADR).
CAPS Rating 4 out of 5
702 Outperform
46 Underperform
CAPS All Stars
153 Outperform
8 Underperform

How do you think AstraZeneca plc (ADR) will perform against the market?

You pick for AstraZeneca plc (ADR) is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Pascal Soriot, CEO

81% Approve

Based on 264 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for AstraZeneca plc (ADR).

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers